Target intelligence / Profile preview

Natural killer cytotoxicity pathway

Molecular classification
Other (biological pathway; not a single molecule, receptor, or protein family)
01

Overview

The natural killer cytotoxicity pathway is the collection of molecular mechanisms by which natural killer (NK) cells identify and destroy abnormal cells, such as cancerous or infected cells. This involves multiple activating and inhibitory surface receptors on NK cells (e.g., natural cytotoxicity receptors, NKG2D, KIRs), complex signaling cascades (involving molecules like DAP10, DAP12, PI3K, Vav1, MAPK), immunological synapse formation, and subsequent exocytosis of cytotoxic granules containing perforin and granzymes leading to apoptosis of the target cell[1][3][4][5][7][8]. Additionally, death receptor pathways (such as Fas/FasL and TRAIL/TRAIL-R interactions) contribute to NK-mediated killing[1][8]. The "pathway" is not a discrete molecule but a regulated sequence of events across a network of interacting proteins. Key point: If you need information about a specific molecule in this pathway (e.g., NCR1 [NKp46], NKG2D, or CD16), you should specify that molecule or receptor. The term "Natural killer cytotoxicity pathway" itself is too broad for mapping to a single canonical target.

Other names
Natural killer cell cytotoxicityNK cell cytotoxicityNK cytotoxic pathwayNatural killer cell-mediated cytotoxicity
02

Biological functions

Immune responseCell deathApoptosisTumor surveillanceAntiviral defense
03

Disease associations

CancerInfectionInflammationImmune disorders

Beyond the preview

Go deeper on Natural killer cytotoxicity pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural killer cytotoxicity pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call